Literature DB >> 15075791

Cancer of the gastrointestinal tract: early detection or early prevention?

P Rozen1.   

Abstract

Gastrointestinal cancer is a major medical and economic burden worldwide. Oesophageal and gastric cancers are most common in the non-industrialized countries, while colorectal cancer is the predominant gastrointestinal malignancy in westernized countries. Their aetiology is mainly related to correctable and preventable lifestyle habits; namely diet (including obesity), physical activity, alcohol and tobacco intake, and sanitation. Prevention and/or treatment of Helicobacter pylori infection would significantly reduce the prevalence of gastric cancer. Screening for cancer, its early detection and treatment requires medical facilities, endoscopic expertise and a major investment of national financial resources. This is only feasible in affluent industrialized countries such as Japan for gastric cancer, some western countries for oesophageal and colorectal cancer. Only population screening for colorectal cancer has been proven feasible and cost-beneficial.

Entities:  

Mesh:

Year:  2004        PMID: 15075791     DOI: 10.1097/00008469-200402000-00011

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  13 in total

1.  Effectiveness of the immunofecal occult blood test for colorectal cancer screening in a large population.

Authors:  Haiyun Yang; Zhizheng Ge; Jun Dai; Xiaobo Li; Yunjie Gao
Journal:  Dig Dis Sci       Date:  2010-05-11       Impact factor: 3.199

Review 2.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

3.  Changes in risk perceptions in relation to self-reported colorectal cancer screening among first-degree relatives of colorectal cancer cases enrolled in a randomized trial.

Authors:  Beth A Glenn; Alison K Herrmann; Catherine M Crespi; Cynthia M Mojica; L Cindy Chang; Annette E Maxwell; Roshan Bastani
Journal:  Health Psychol       Date:  2011-07       Impact factor: 4.267

4.  Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer.

Authors:  Chuan Zhang; Nobutaka Yamada; Yun-Lin Wu; Min Wen; Takeshi Matsuhisa; Norio Matsukura
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

5.  The cag pathogenicity island of Helicobacter pylori is disrupted in the majority of patient isolates from different human populations.

Authors:  Farhana Kauser; Aleem A Khan; M Abid Hussain; Ian M Carroll; Naheed Ahmad; Santosh Tiwari; Yogesh Shouche; Bimal Das; Mahfooz Alam; S Mahaboob Ali; C M Habibullah; Rafaela Sierra; Francis Megraud; Leonardo A Sechi; Niyaz Ahmed
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

6.  Rates and sociodemographic correlates of cancer screening among South Asians.

Authors:  Beth A Glenn; Neetu Chawla; Zul Surani; Roshan Bastani
Journal:  J Community Health       Date:  2009-04

7.  Histopathologic Prolife of Primary Gastrointestinal Malignancies in Uyo City (Niger-Delta Region of Nigeria).

Authors:  Emmanuel K Abudu; Oluyinka S Akinbami
Journal:  Rare Tumors       Date:  2016-04-06

8.  Lowly expressed ribosomal protein s19 in the feces of patients with colorectal cancer.

Authors:  Chih-Cheng Chien; Tien-Chien Tu; Chi-Jung Huang; Shung-Haur Yang; Chia-Long Lee
Journal:  ISRN Gastroenterol       Date:  2012-01-09

9.  High diversity of vacA and cagA Helicobacter pylori genotypes in patients with and without gastric cancer.

Authors:  Yolanda López-Vidal; Sergio Ponce-de-León; Gonzalo Castillo-Rojas; Rafael Barreto-Zúñiga; Aldo Torre-Delgadillo
Journal:  PLoS One       Date:  2008-12-03       Impact factor: 3.240

10.  Faecal ribosomal protein L19 is a genetic prognostic factor for survival in colorectal cancer.

Authors:  C-J Huang; C-C Chien; S-H Yang; C-C Chang; H-L Sun; Y-C Cheng; C-C Liu; S-C Lin; C-M Lin
Journal:  J Cell Mol Med       Date:  2008-02-04       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.